NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2

Clinical trials for NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2 explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2 trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New radioactive therapy shows promise for hard-to-treat thyroid cancer

Disease control Ongoing

This early-phase study tests a radioactive drug (177Lu-PP-F11N) that targets a receptor found on most medullary thyroid cancer cells. The goal is to see if it can safely image and treat advanced cancers that have spread. About 24 adults with medullary thyroid cancer or certain ot…

Matched conditions: NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2

Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control

Last updated May 17, 2026 12:28 UTC

NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2

Get alerted when new NEUROENDOCRINE TUMOR OF THE LUNG GRADE 1 AND 2 trials appear

New radioactive therapy shows promise for hard-to-treat thyroid cancer